Clinical Trial Update: Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intraluminal metronidazole powder as monotherapy for Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Metronidazole intraluminal powder (metronidazole)

Snippet

Sponsor: Mackay Memorial Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED